First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.
Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, Bugat R, Burger U, Garin A, Graeven U, McKendric J, Maroun J, Marshall J, Osterwalder B, Pérez-Manga G, Rosso R, Rougier P, Schilsky RL; Capecitabine Colorectal Cancer Study Group.
Cassidy J, et al. Among authors: graeven u.
Ann Oncol. 2002 Apr;13(4):566-75. doi: 10.1093/annonc/mdf089.
Ann Oncol. 2002.
PMID: 12056707
Free article.
Clinical Trial.